by Abdelhamid | May 31, 2024
The CRUCIAL consortium held its second General Assembly on February 10, 2022.
The meeting was held virtually once again, during which all consortium representatives discussed and decided to extend the project’s duration by one year.
The COVID-19 pandemic had a particularly significant impact on CRUCIAL compared to other research projects. This was largely due to the nature of our studies, which involve conditions that increase vulnerability to COVID-19, and because many of the physicians involved were reassigned to patient care during the pandemic.
by Abdelhamid | May 31, 2024
To ensure productive collaboration, the CRUCIAL partners involved in the basic science work packages of the project hold regular meetings.
These meetings include representatives from Maastricht University (UM), the Flanders institute for biotechnology (VIB) and KU Leuven (KUL).
So far, they met on:
- October 16, 2023
- November 20, 2023
- December 18, 2023
- March 18, 2024
- April 15, 2024
- April 22, 2024
by Abdelhamid | May 31, 2024
To ensure productive collaboration, the CRUCIAL partners involved in the clinical aspects of the project hold regular meetings.
These meetings include representatives from Maastricht University (UM), the University of Navarra (UNAV), the Centre for Applied Medical Research (CIMA), and University College London (UCL).
So far they have met on:
- September 21, 2021 (UM, UNAV, UCL and CIMA)
- November 23, 2021 (UM, UNAV, UCL and CIMA)
- January 14, 2022 (UCL and CIMA)
- January 18, 2022 (UM, UNAV, UCL and CIMA)
- February 4, 2022 (UCL and CIMA)
- March 22, 2022 (UM, UNAV, UCL and CIMA)
- June 16, 2022 (UM, UNAV, UCL and CIMA)
- September 21, 2022 (UM, UNAV, UCL and CIMA)
- December 1, 2022 (UM, UNAV, UCL and CIMA)
- January 18, 2023 (UM, UNAV, UCL and CIMA)
- June 28, 2023 (UM, UNAV, UCL and CIMA)
- July 19, 2023 (UM, UNAV, UCL and CIMA)
- September 6, 2023 (UM, UNAV, UCL and CIMA)
- November 28, 2023 (UM, UNAV, UCL and CIMA)
- December 13, 2023 (UM, UNAV, UCL and CIMA)
by Abdelhamid | May 31, 2024
The CRUCIAL consortium held its first General Assembly on February 9, 2021.
This virtual gathering provided a valuable opportunity for all partners to collaboratively evaluate and discuss the impacts of the COVID-19 pandemic on the project.
This project has received funding from the SESAR Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848109.